GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and ...

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) ...

The authors confirm that telomeres in telomerase-positive cells terminate with 5'-ATC in a Pot1-dependent manner, and demonstrate that this principle holds true in telomerase-negative ALT cells as ...

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to dateInitiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expect ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

The startup is also launching a tool called Figma Draw for vector editing and illustrations. Yamashita said that designers often had to export their vector designs outside Figma to make edits.

a biotechnology company pioneering the development of novel genetic medicines, today announced it has secured a $5 million ...

This key milestone is marked as a 'game changer' by the Ploug Group at the University of Copenhagen's Biotech Research & Innovation Centre ... partially filled and full adeno-associated virus (AAV) ...

In the world of technology, every day, we come across multiple news stories that hit the headlines in terms of funding, ...

Elevate your React Native applications with the power of customizable vector icons. Ideal for embellishing buttons, logos, and navigation or tab bars, these icons seamlessly integrate into your ...

Very simple GitHub profile readme that randomizes the order of icons in each section multiple times per day using GitHub actions.